Hydrocodone Extended-Release Capsules and Necitumumab Intravenous
Determining the interaction of Hydrocodone Extended-Release Capsules and Necitumumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
Generic Name: necitumumab
Brand name: Portrazza
Synonyms: Necitumumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydrocodone Extended-Release Capsules-Necon
- Hydrocodone Extended-Release Capsules-Necon 0.5/35
- Hydrocodone Extended-Release Capsules-Necon 1/35
- Hydrocodone Extended-Release Capsules-Necon 1/50
- Hydrocodone Extended-Release Capsules-Necon 1/50 (28)
- Hydrocodone Extended-Release Capsules-Necon 7/7/7
- Necitumumab Intravenous-Hydrocodone Extended-Release Tablets
- Necitumumab Intravenous-Hydrocodone Polistirex and Chlorpheniramine Polistirex Suspension
- Necitumumab Intravenous-Hydrocodone, Chlorpheniramine, and Pseudoephedrine
- Necitumumab Intravenous-Hydrocodone, Pseudoephedrine, and Guaifenesin
- Necitumumab Intravenous-Hydrocortisone
- Necitumumab Intravenous-Hydrocortisone (Systemic)